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ABSTRAK
Penyakit kekurangan glucose-6-phosphate-dehyrogenase (G6PD) merupakan 
penyakit kekurangan enzim paling lazim di dunia termasuklah Malaysia. Saringan 
kekurangan separa enzim ini menggunakan darah tali pusat adalah sangat penting 
memandangkan mereka juga berisiko untuk mendapat hemolisis akut. Dalam 
kajian ini, kadar prevalens bagi kekurangan separa G6PD ditentukan dengan 
menggunakan kit ujian OSMMR-D dimana ianya mengintegrasikan kaedah 
pernormalan hemoglobin dan kadarnya dibandingkan dengan kaedah ujian titik 
pendafluoran (FST). Sejumlah 236 subjek dari kalangan kanak-kanak, berumur 
di antara 1 bulan hingga 12 tahun dan; 614 bayi-bayi perempuan telah dipilih 
untuk kajian ini. Penentuan julat normal aktiviti G6PD dan; paras penentu untuk 
kekurangan separa dan sepenuhnya ditentukan mengikut WHO Working Group 
(1989). Kadar prevalens untuk kekurangan separa untuk kedua-dua kumpulan 
pesakit (perempuan) dibuat menggunakan kit esei enzim ini dan keputusannya 
dibandingkan dengan FST. Dalam kajian ini, didapati 15.7% (18/115)  kanak-kanak 
perempuan diklasifikasikan kekurangan separa G6PD menerusi kaedah ujian esei 
enzim (aktiviti G6PD: 4.23-5.26U/gHb), tetapi FST hanya dapat mengesan 0.9% 
(1/115) yang mempunyai aktiviti G6PD minimal. Kadar prevalens kekurangan separa 
G6PD pada bayi-bayi perempuan adalah 3.42% (21/614) menggunakan ujian esei 
enzim berbanding 0.49% (3/614) menggunakan FST. Kesimpulannya, hasil kajian 
ini membutikan bahawa ujian FST gagal mengesan pesakit kekurangan separa 
G6PD (heterozigot). Sehubungan dengan itu, kami menyarankan penggunaan 
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ujian kuantitatif esei G6PD dengan OSMMR-D kit memandangkan ianya lebih 
sensitif untuk mengesan penyakit kekurangan G6PD dalam bayi-bayi perempuan 
berbanding dengan FST.
Kata kunci: separa, kekurangan G6PD, enzim, esei, FST
ABSTRACT
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common 
enzyme deficiency worldwide including Malaysia. Screening of cord blood for 
partial G6PD deficiency is important as they are also prone to develop acute 
haemolysis. In this study, we determined the prevalence of partial G6PD deficient 
in paediatric population aged 1 month-12 years and normal term female neonates 
using OSMMR-D kit with haemoglobin (Hb) normalization and compare it with 
florescence spot test (FST). A total of 236 children, aged between between 1 
month-12 years and 614 normal term female neonates were recruited for this study. 
Determination of normal means for G6PD activity and; cut-off points for partial 
and severe deficiency were determined according to WHO Working Group (1989). 
Determination of prevalence for partial deficiency for both groups (female patient) 
was done using this enzyme assay kit and findings were compared with FST. In this 
study, 15.7% (18/115) female children were classified as partial G6PD deficient by 
quantitative enzyme method (G6PD activity: 4.23-5.26U/gHb). However, FST only 
detected 0.9% (1/115) with minimal G6PD activity. The prevalence of partial G6PD 
deficiency in female neonate group was 3.42% (21/614) by enzyme assay versus 
0.49% (3/614) by FST. This study concluded that our routine screening method 
using FST was unable to diagnose female heterozygotes. We recommend using this 
quantitative enzyme assay method by OSMMR-D kit since it was more sensitive in 
detecting G6PD deficiency in female neonates compared to FST.
Keywords: partial, G6PD deficiency, enzymes, assay, FST
enzyme deficiency ranging from 20% 
to 60% of the normal residual activity. 
Detection of partially deficient G6PD 
individuals is important as they too 
are prone to develop acute hemolysis 
(Luzzatto & Mehta 1995).
 In a study conducted by Reclos et 
al. (2000) involving 2000 neonates, it 
was found that FST was able to detect 
all male neonates with severe G6PD 
deficiency in which the G6PD activity 
INTRODUCTION
Glucose-6-phosphate dehydrogenase 
(G6PD) deficiency is the common 
cause of neonatal jaundice in Malaysia. 
Neonatal screening for G6PD 
deficiency in Malaysia using the FST has 
long been established since 1980. The 
fallback of screening G6PD deficiency 
by this method is that semiquantitative 
test is not reliable in detecting female 
heterozygotes whereby they may have 
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was less than 2.1 U/gHb (less than 
20% of the normal residual activity). 
However, FST misclassified almost 
all cases with G6PD enzyme activity 
between 20- 60% of the normal residual 
which was interpreted as normal 
FST. These cases were found to be 
exclusively in females. These findings 
were in concordance with a local study 
by Ainoon et al. (2003) involving 976 
neonates. The study demonstrated 
that 46.3% of the cases with partial 
G6PD deficiency were misclassified 
as normal by FST with enzyme activity 
ranging from 2.92 to 8.7 U/gHb. They 
were found to be exclusively females, 
as well. Both studies emphasized on 
the importance of correct classification 
and proposed the employment of fully 
quantitative method as a screening tool, 
in which the partially G6PD deficient 
patients are also at risk of developing 
acute haemolytic crises similar to their 
male counterparts. 
 The OSMMR2000-D G6PD assay 
is a quantitative enzyme assay. This 
kit offers rapid, fully automated, 
quantitative measurement of G6PD 
coupled to a simultaneous evaluation 
of the haemoglobin (Hb) content in 
the sample, expressing the results in 
Units/gram haemoglobin (U/gHb). Hb 
normalization will allow for correction 
of all samples against a selected 
standard or control used in the test 
by ‘normalizing’ all analyte values 
so that they correspond to the same 
quantity of sample (Azma et al. 2010) 
had established the normal reference 
range for G6PD enzyme activity level 
in Malaysian neonates and adults using 
this kit.  The overall mean value for 
neonate and adult population were 
12.43±2.28 U/gHb and 9.21 U/gHb 
respectively. The normal reference 
range for neonate population was 
10.15-14.71 U/gHb while the adult 
population was lower, between 6.61-
11.81 U/gHb.  In this study, there were 
no significant differences in mean G6PD 
activity between males and females 
for Chinese and Malays. This lack of 
difference in red cell G6PD activity 
level among ethnic and gender groups 
has been reported previously in Malays 
and Chinese in Malaysia using Sigma 
kit (Ainoon et al. 2003).  Measurement 
of G6PD activity using OSMMR-D kit is 
slightly more expensive and laborious 
compare to FST. However, this test is 
far more sensitive in detecting partial 
G6PD individuals (Azma et al. 2010).
In this study, we established the 
normal range of G6PD activity using 
OSMMR-D kit with haemoglobin (Hb) 
normalization for paediatric population 
age one month to 12 years old. We also 
determined the prevalence of partial 
G6PD deficient in this population and 
normal term female neonates using 
similar enzyme assay kit and compared 
it with FST.
MATERIALS AND METHODS
A total of 236 subjects from paediatric 
population aged between 1 month- 
12 years, who received treatment 
at Universiti Kebangsaan Malaysia 
Medical Centre (UKMMC) and 614 
term female neonates born in UKMMC 
were enrolled in this study. The 
patients’ peripheral blood samples and 
cord blood in EDTA tube were sent to 
the Haematology Unit, Department 
of Diagnostic Laboratory Services, 
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UKMMC. 
 For the establishment of normal 
range, selected paediatric blood 
samples were tested for full blood count 
using fully automated haematology 
analyzer (Coulter®GENS). Those 
with normal haemoglobin level were 
included in this study.
 For FST, samples were applied to 
Whatman’s filter paper and dried at 
room temperature. The test was carried 
out according to the method described 
by Beutler and Mitchell (1968). The 
spot was examined for fluorescence 
production from reduced pyridine 
nucleotide (NADPH) under a long-
wave ultraviolet light source. Those 
with normal FST were included in 
the determination of normal range for 
G6PD activity and cut-off points for 
partial G6PD deficiency. Those showed 
minimal G6PD activity with FST were 
included in the prevalence of partial 
G6PD deficiency study.
 For the quantitation of G6PD 
activity, we used the OSMMR2000-D 
G6PD assay kit with haemoglobin 
normalization from R&D Diagnostics 
(Holargos, Greece). The measurement 
of enzyme activity was done using a 
spectrophotometer (Ultramicroplate 
Reader EL808, Bio Tek, Instruments). 
Method for quantitation of G6PD 
activity using this assay kit has been 
described in a previous study (Azma et 
al. 2010).
 Normal probability plots for 
variables of normal paediatric samples 
in each subgroup by age, sex and race 
were carried out to ascertain that the 
distribution was normal. Analysis of 
variance for the level of G6PD enzyme 
activity by sex, ethnic origin and 
age groups was carried out. This was 
followed by comparison of means in 
G6PD assay values between sex, ethnic 
origin and different age groups. A result 
of p<0.05 was considered as statistically 
significant. Then the means, SD, ranges 
of G6PD activity for this paediatric 
group were determined. A 20% and 
60% cut-off point for the diagnosis of 
severe and partial G6PD deficiency 
respectively, were also established 
in this group (WHO Working Group 
1989).
 For female neonates group, their 
cord blood samples were sent for FST 
analysis and quantitation of G6PD 
activity by OSMMR-D G6PD assay with 
Hb normalization. Prevalence of partial 
G6PD deficiency was determined in 
both paediatric and female neonatal 
group and findings were compared 
between the two methods.
RESULTS
NORMAL MEAN OF G6PD 
ACTIVITY IN CHILDREN AGED 1 
MONTH TO 12 YEARS OLD
From 236 paediatric subjects, aged 
between 1 month-12 years, only 
214 subjects were included for the 
determination of normal reference 
range for G6PD activity. The other 22 
subjects had absent or minimal enzyme 
activity by FST and G6PD enzyme assay 
showed G6PD activity less than 6.5U/
gHb. They were considered as outliers 
and were excluded from the analysis. 
Out of 214 subjects, 117 were males 
(54.7%) and 97 were females (45.3%). 
Majority of the subjects recruited were 
Malays with 66.1% (n=156), followed 
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by Chinese 18% (n=43), Indians 2.5% 
(n=6) and others 3.8% (n=9). There 
were no significant differences in the 
mean normal G6PD activity among 
age groups (Table 1). There were also 
no significant differences in the mean 
normal G6PD activity among races 
(Table 2), and among gender in each 
racial group (Table 3). 
 The overall mean value for normal 
G6PD activity was 10.18±3.36 U/gHb 
(2SD). The reference range for normal 
G6PD activity established from this 
population was 6.82-13.54 U/gHb. The 
upper and lower limit cut-off points for 
partial G6PD deficiency were 6.11 U/
gHb (60% of the normal mean) and 
2.03 U/gHb (20% of normal mean), 
respectively (as recommended by WHO 
Working Group (1989). The upper limit 
for total/severe deficiency was 2.03 U/
gHb (20% of the normal mean G6PD 
activity for paediatric population). The 
intrabatch and interbatch coefficient 
of variance for samples with normal 
G6PD enzyme activity level was 4.6%. 
PREVALENCE OF PARTIAL G6PD 
DEFICIENCY IN CHILDREN AGED 
1 MONTH TO 12 YEARS OLD IN 
UKMMC
The analysis for prevalence of partial 
G6PD deficiency by FST and enzyme 
assay was based on 236 samples. The 
results of screening for partial G6PD 
deficiency by FST and OSMMR-D 
kit were shown in Table 4. In male 
paediatric group, none of them were 
found to be G6PD partially deficient 
either by FST or enzyme assay. There 
was one out of 115 cases (0.9%) in 
female paediatric group which showed 
minimal enzyme activity by FST, while 
18 cases (15.7%) were identified as 
partial G6PD deficiency by quantitative 
enzyme assay. Therefore, only one 
case of partial G6PD deficiency was 
detected by routine FST and was later 
confirmed with enzyme assay. The 
other 17 (14.8%) cases which had 
normal FST were not detected by this 
method. These children with partial 
G6PD deficiency had enzyme activity 
level ranged from 4.23-5.26 U/gHb.
PREVALENCE OF PARTIAL G6PD 
DEFICIENCY AMONG FEMALE 
NEONATES BORN IN UKMMC
A total of 614 term female neonates 
(459 Malays, 124 Chinese, 13 Indians 
and 18 others) were enrolled in this 
study. The overall mean normal G6PD 
activity and cut-off points for partial 
G6PD deficiency used in this study 
were based on study done by Azma et 
al. (2010).  
 For this study, 21 (3.42%) female 
neonates were found to have G6PD 
activity between 20-60% of the normal 
mean (2.03U/gHb-6.12U/gHb) by 
OSMMR-D kit and three cases were 
diagnosed by FST method (Table 5).  
 Racial breakdown showed that 
2.28% (14 cases) were Malays, 0.98% 
(6 cases) were Chinese and 0.16% (one 
case) were Indian neonates diagnosed 
by OSMMR-D kit (Table 6). In the 
female Malay neonates group, only 
two (0.44%) cases were interpreted 
as minimal on FST while 12 other 
cases (2.61%) were normal by this 
method. All 14 (3.05%) cases of partial 
G6PD deficiency including two cases 
diagnosed by FST method were readily 
detected by OSMMR-D kit. The G6PD 
enzyme activity levels ranged from 
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Table 1: G6PD activity levels in different age groups in children age 1 month-12 years old
Age group No. of cases Mean G6PD activity (U/gHb)
Upper limit of total 
deficiency 
(20% of mean value)
Upper limit of 
partial deficiency 
(60% of mean value)
1 month-1 year 24 9.64±3.34 1.93 5.78
1-2 year 37 10.85±2.94 2.17 6.51
3-4 year 34 10.55±3.18 2.11 6.33
5-6 year 24 9.73±3.76 1.95 5.84
7-8 year 33 10.05±2.42 2.01 6.03
9-10 year 26 9.85±3.60 1.97 5.91
11-12 year 36 10.17±3.84 2.03 6.10
Total 214 10.18±3.34 2.04 6.11
There were no significant differences in the mean G6PD activity among different age groups in children age 1 month to 12 
years old (p>0.05).
Table 2: G6PD activity levels in different ethnic group for children age 1 month-12 years
Ethnic 
group
No. of 
cases
Mean G6PD activity 
(U/gHb)
Upper limit of total 
deficiency 
(20% of mean value) U/gHb
Upper limit of partial 
deficiency 
(60% of mean value) U/gHb
Malay 156 10.28±3.22 2.05 6.14
Chinese 44 10.07±3.68 2.01 6.04
Indians 6 9.01±3.26 1.81 5.45
Others 8 9.81±3.98 1.96 5.89
Total 214 10.18±3.36 2.04 6.12
There were no significant differences in mean normal G6PD activity between various racial groups (p>0.05).
Table 3: G6PD activity levels for normal male and female paediatric group aged 1 month-12 
years old
Races Gender No. of cases
Mean G6PD activity 
(U/gHb)
Upper limit of total 
deficiency 
(20% of mean value) 
U/gHb
Upper limit of partial 
deficiency 
(60% of mean value) 
U/gHb
Malay Male 86 10.40±3.38 2.08 6.24
Female 70 10.12±3.00 2.02 6.07
Chinese Male 23 10.01±3.5 2.00 6.01
Female 21 10.14±3.92 2.03 6.08
Indians Male 3 8.73±2.94 1.75 5.24
Female 3 9.28±4.10 1.86 5.57
Others Male 5 9.12±2.44 1.82 5.47
Female 3 10.95±2.80 2.19 6.57
Total Male 117 10.23±3.42 2.05 6.14
Female 97 10.13±3.30 2.03 6.08
There were no significant differences in the mean G6PD activity between males and females in each racial group (p>0.05)
17
Detection of Partial G6PD Deficiency Using OSMMR2000-D Kit Med & Health 2014; 9(1): 11-21
3.17-7.37 U/gHb. 
 Meanwhile, only one (0.81%) case 
was interpreted as minimal by FST in the 
Chinese female neonates  as compared 
to all six cases (4.84%) diagnosed by 
enzyme assay method. The G6PD 
activity levels for this group range from 
4.02-7.10 U/gHb. The female Indian 
neonate with partial G6PD deficiency 
was only detected by OSMMR-D  kit and 
not diagnosed by FST method.  There 
were no partial G6PD deficient neonates 
detected in other ethnic groups. 
 Therefore, the overall frequencies of 
partial G6PD deficiency detected by 
FST and OSMMR-D kit were 0.49% 
Table 4: Detection of partial G6PD deficiency in paediatric group aged 1 month-12 year by 
FST and enzyme assay
Gender Method
No. cases with 
total deficiency 
(G6PD activity 
<20%)
No. cases 
with partial 
deficiency 
(G6PD activity 
20-60% normal)
No. cases 
with normal 
G6PD activity
Partial G6PD 
deficiency 
individuals 
(%)
Male (n=117) FST 4 0 117 0
G6PD enzyme 
assay
4 0 117 0
Female (n=115) FST 0 1* 114 0.9
G6PD enzyme 
assay
0 18# 97 15.7
*One case of partial G6PD deficiency detected by FST was interpreted as minimal G6PD activity and was 
confirmed by enzyme assay method. 
#The range for partial G6PD deficiency in this paediatric population were between 2.03U/gHb - 6.12U/gHb.
Table 5: Detection of partial G6PD deficiency in female neonates by fluorescent spot test 
and enzyme assay methods.
 
Method No. of cases with 
partial deficiency 
(G6PD activity 20-60%)
No. of cases with 
normal G6PD 
activity
Partial G6PD 
deficient individuals 
(%)
Female (n=614) FST 3* 611 0.49
Enzyme assay 21 593 3.42
*The three cases of partial G6PD deficiency detected by FST were interpreted as minimal G6PD activity and 
confirmed by enzyme assay.
Table 6: G6PD activity in partial G6PD deficiency and overall frequency according to 
ethnic group, by fluorescent spot test and enzyme assay methods.
Ethnic group No. (frequency) diagnosed 
by fluorescent spot test
No. (frequency) diagnosed by 
enzyme method
Partial G6PD 
deficiency (%)
Malay (n=459) 2 (0.44%) 14 (3.05%) 3.05
Chinese (n=124) 1 (0.81%) 6 (4.84%) 4.84
Indians (n=13) 0 1 (7.69%) 7.69
Others (n=18) 0 0 0
Total (n=614) 3 (0.49%) 21 (3.42%) 3.42
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and 3.42%, respectively. 
DISCUSSION
Quantitative enzyme assay however is 
not routinely available in most hospitals 
in Malaysia. In our Haematology 
Laboratory, we have had introduced 
quantitative enzyme assay using 
OSMMR2000-D kit employing the Hb 
normalization technique and normal 
range for G6PD activity for neonates 
and adults in our laboratory using this 
kit have been established (Azma et al. 
2010).  In this study, we established 
the normal range, the mean and the 
standard deviations for G6PD activity 
for paediatric population age 1 month 
to 12 years old.    
 The overall mean value for paediatric 
population age 1 month-12 years old 
was 10.18 ± 3.36 U/gHb. Comparing the 
mean normal value of G6PD activity for 
neonates and adults (12.43 U/gHb and 
9.20 U/gHb, respectively) which have 
been established earlier, (Azma et al. 
2010) the mean normal value of G6PD 
activity in this paediatric population 
age 1 month-12 years old falls between 
these two values. This was probably 
due to presence of circulating young 
red cells which was known to be higher 
in neonates and gradually decreased 
as they get older. The young red cells 
(reticulocytes) contained higher G6PD 
activity than mature red cells. Apart 
from that, contamination with high 
total white cells during hemolysate 
preparation in neonates may contribute 
to higher G6PD activity level in this 
population.  
 We also compared the mean 
values for G6PD activity among 
different age groups in this paediatric 
population and there was no significant 
differences (p>0.05). As this study 
recruited paediatric population age 
between one month till 12 years old, 
therefore variation in the haemoglobin 
level among various groups need 
to be considered as well. In normal 
physiology, immediately after birth, 
the rates of Hb synthesis and red 
cell production fall fairly steeply to a 
minimum level by the second month 
of life, in response to the sudden 
increase in the tissue oxygenation 
at birth. In our setting, term babies 
have mean Hb value of 15g/dL at four 
weeks and 12.4g/dL by eight weeks 
and slowly reduced to about 12.1g/dL 
by 6-8 month of life. However, there 
is a slight dip in the mean Hb noticed 
after 6 to 12 month with a mean Hb 
of 11.6g/dL but later the level sustained 
between 11 – 13g/dL. The reticulocytes 
count fall after birth as erythropoeisis 
is suppressed and increases to normal 
values by 6-8 weeks of age.  With the 
rise in 2,3-DPG level and fall in Hb 
F level in the first few month of life, 
the haemoglobin-oxygen dissociation 
curve gradually shifts to the right, which 
lead to increase in delivery of oxygen 
to the tissue and hence, ameliorating 
the effect of falling Hb. Therefore, the 
mean Hb level in paediatric population 
between age 1 month and 12 years 
old varies between 11.6-15.0g/dL. As 
compared to the neonate population, 
the Hb and reticulocytes level is higher 
and therefore the mean for G6PD 
enzyme level is expected to be higher 
in this group. This normal physiological 
fluctuation in Hb levels defines the 
need for a method that can ‘normalize’ 
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the Hb level so that the level of G6PD 
enzyme level will not be affected. 
 The mean normal for G6PD activity 
between male and female children in 
various age groups also showed no 
significant differences (p>0.05).  Similar 
findings also seen in neonates and 
adult population in a study done by 
Azma et al. (2010) where it was shown 
that gender did not affect the G6PD 
enzyme activity level in their respective 
population.   
 The comparison of mean normal 
for G6PD enzyme activity in various 
ethnic groups showed no significant 
differences (p>0.05).  There were also 
no significant differences in the mean 
normal G6PD activity between male 
and female in various ethnic groups 
(p>0.05). Similar findings have been 
described by Azma et al. (2010)  in 
neonates and adult populations, 
however they only compared two 
major ethnic groups in Malaysia, 
namely Malays and Chinese. Ainoon 
et al. (2003) has also described similar 
findings by using the Randox G6PD kit.
In this study, the cut-off point for G6PD 
deficiency in paediatric population 
was 6.12 U/gHb and the range for 
partial G6PD deficiency was 2.04-
6.12 U/gHb. The range for partial 
G6PD deficiency for neonate and adult 
population by Azma et al. (2010) were 
2.5-7.4 U/gHb and 1.84-5.52 U/gHb, 
respectively. Therefore the range for 
partial G6PD deficiency established 
for the paediatric population from this 
study was expected to fall in between 
the neonate and adult ranges.
 Prevalence of partial G6PD 
deficiency detected by both FST 
and G6PD enzyme assays were 
determined in all 236 subjects. None 
of the male children (121) had partial 
G6PD deficient. However there were 
four male children with severe G6PD 
deficiency detected by both methods. 
Their G6PD activity level was <2.04 U/
gHb. 
 In the female children group, one out 
of 115 cases (0.9%) had minimal G6PD 
activity by FST and was confirmed 
partial G6PD deficiency by quantitative 
G6PD enzyme assay. Meanwhile, the 
quantitative G6PD assay was able to 
pick up 18 cases (15.7%) with G6PD 
deficiency including the sample 
detected by FST. Therefore, the FST 
misdiagnosed 14.8% subjects as 
normal. The residual G6PD activity 
ranged from 41.6%-51.7% (4.23-5.26 
U/gHb). These cases were classified 
as partial G6PD deficiency. A study 
by Wolf et al. (1987) revealed that 
sensitivity of FST for detection of partial 
G6PD deficiency was low (32%) as 
compared to detection of total male 
G6PD deficient. 
 In this study, we found that the 
overall prevalence of G6PD deficiency 
by FST was 2.12% (5/236), but by 
using quantitative enzyme assay the 
prevalence was 9.32%. Therefore, 
semiquantitative screening test 
failed to detect children with partial 
G6PD deficiency but no problems 
in detecting those with severe G6PD 
deficiency. These findings were 
supported by previous study that 
conducted in neonate population in 
Hospital Kuala Lumpur which showed 
that semiquantitative method was able 
to detect neonate with severe G6PD 
deficiency if G6PD activity was less 
than 20% of normal mean (Boo et al. 
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1994).  Therefore, screening with FST 
was able to diagnose male neonates 
with severe G6PD deficiency.
 In this study we also looked at the 
prevalence of partial G6PD deficiency 
in 614 female neonates born in 
UKMMC. The cut-off points for partial 
G6PD in this population were based 
on a study done by Azma et al. (2010). 
The established range for partial G6PD 
deficiency for this population was 
2.5-7.4U/gHb. Subjects with enzyme 
activity within this range were classified 
as partial G6PD deficiency. From 614 
subjects, 21 (3.42%) had G6PD activity 
level between 20 - 60% of the normal 
mean by enzyme assay method and 
only three cases showed minimal 
G6PD activity by FST. 
 The prevalence of partial G6PD 
in female neonates by using FST and 
quantitative enzyme assay were 0.49% 
and 3.42% respectively. Therefore, 
these indicate that 2.93% (18) cases 
were missed by routine screening test 
and these cases were found to be partial 
G6PD deficiency. These findings were 
supported by a study by Ainoon et al. 
(2003)  involving 976 neonates (both 
male and female neonates), they found 
that the overall prevalence by using 
FST and quantitative enzyme assay 
were 3.28% and 7.17%, respectively, 
which conclude that semiquantitative 
screening method failed to diagnose 
3.9% of neonates with G6PD deficiency, 
and all were female. Another study by 
Reclos et al. (2000) recruiting 2150 
neonates revealed that 24 subjects 
classified as normal by FST found to be 
partially deficient by the quantitative 
enzyme method and they too were all 
female. The rate of detection was much 
higher by enzyme method and had 
good sensitivity and specificity whereby 
all cases detected by FST were readily 
diagnosed by this quantitative method. 
Meanwhile FST tend to give negative 
result for mild to moderate deficiencies. 
This could also possibly explain the 
misdiagnosis of 44% of infants with 
severe hyperbilirubinaemia in Malaysia 
(Selvaraju 1999).
 In conclusion, the OSMMR-D G6PD 
kit is excellent in detecting partial 
G6PD deficiency in female population. 
Since, the FST does not appear to miss 
G6PD deficient males, it is proposed 
that for financial reasons, quantitative 
screening could be limited to female 
neonates. The test is easy to perform, 
less laborious, more sensitive, rapid 
produce results with affordable cost.
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